Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
Pre-Market Last Trade |
Last: $ 1.68 ▼ -0.12 (-6.67%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 1.80 | 0.00 | 0.00 | 0.00 | 1.80 | 08:05:49 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.68 | 1.70 | 0.02 | 1.18% | - | - |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 219 | 89,595 | 1,193,038 | 0.74 - 15.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:05:44 | formt | 100 | $ 1.68 | USD |
Aclaris Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 74.46M | 41.37M | $ -132.74M | -4.04 | - | 39.59M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aclaris Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.14 | 2.32 | 1 | 1.7561 | 7M | 0.66 | 57.89% |
| 1 Month | 0.9549 | 2.32 | 0.8585 | 1.5980 | 2M | 0.8451 | 88.50% |
| 3 Months | 4.45 | 4.6 | 0.74 | 1.5426 | 2M | -2.65 | -59.55% |
| 6 Months | 5.61 | 7.51 | 0.74 | 2.6812 | 1M | -3.81 | -67.91% |
| 1 Year | 15.05 | 15.98 | 0.74 | 4.5632 | 781k | -13.25 | -88.04% |
| 3 Years | 25.04 | 33.25 | 0.74 | 12.4209 | 439k | -23.24 | -92.81% |
| 5 Years | 11.94 | 33.88 | 0.74 | 12.7018 | 348k | -10.14 | -84.92% |
Aclaris Therapeutics Description
| Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively. |
